Literature DB >> 32911562

The Certainty Framework for Assessing Real-World Data in Studies of Medical Product Safety and Effectiveness.

Noelle M Cocoros1, Peter Arlett2,3, Nancy A Dreyer4, Chieko Ishiguro5, Solomon Iyasu6, Miriam Sturkenboom7, Wei Zhou6, Sengwee Toh1.   

Abstract

A fundamental question in using real-world data for clinical and regulatory decision making is: How certain must we be that the algorithm used to capture an exposure, outcome, cohort-defining characteristic, or confounder is what we intend it to be? We provide a practical framework to help researchers and regulators assess and classify the fit-for-purposefulness of real-world data by study variable for a range of data sources. The three levels of certainty (optimal, sufficient, and probable) must be considered in the context of each study variable, the specific question being studied, the study design, and the decision at hand.
© 2020 The Authors Clinical Pharmacology & Therapeutics © 2020 American Society for Clinical Pharmacology and Therapeutics.

Year:  2020        PMID: 32911562     DOI: 10.1002/cpt.2045

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

Review 1.  The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework.

Authors:  Nicolle M Gatto; Ulka B Campbell; Emily Rubinstein; Ashley Jaksa; Pattra Mattox; Jingping Mo; Robert F Reynolds
Journal:  Clin Pharmacol Ther       Date:  2021-12-01       Impact factor: 6.903

2.  The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making.

Authors:  Paul Cottu; Scott David Ramsey; Oriol Solà-Morales; Patricia A Spears; Lockwood Taylor
Journal:  Breast       Date:  2021-12-22       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.